GSK penicillin acquisition closed by Dr. Reddy’s
Dr. Reddy’s Laboratories has wrapped up its acquisition of GlaxoSmithKline’s U.S. oral penicillin facility and product portfolio. With the deal, which was announced last November, Dr. Reddy’s takes over the GlaxoSmithKline’s penicillin manufacturing site in Bristol, Tenn.